AMAG Pharma (AMAG) Tops Q2 EPS by 25c

August 9, 2016 7:32 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of $1.45, $0.25 better than the analyst estimate of $1.20. Revenue for the quarter came in at $127.4 million versus the consensus estimate of $128.52 million.


AMAG Pharma sees FY2016 revenue of $503-553 million, versus the consensus of $533.8 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment